Phase 2 FGFR Gene Alterations Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Low-grade NMIBCFGFR Gene AmplificationFGFR Gene Alterations+3 more

Tyra Biosciences, Inc90 enrolled35 locationsNCT06995677

Recruiting

Phase 2

NCCH2006/MK010 Trial (FORTUNE Trial)

FGFR Gene AlterationsAdvanced or Recurrent Solid Tumors

National Cancer Center, Japan75 enrolled7 locationsNCT04962867